Kissimmee, Fla. — The time it takes for the U.S. Food and Drug Administration (FDA) approval of a new dermatology drug or treatment depends on many factors, including how closely pharmaceutical companies cooperate with the agency.
Addressing Quality of Life Specifics Associated With Atopic Dermatitis and Skin of Color
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients
Renata Block, PA-C, Reflects on Dermatology Innovations in 2023
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium
Combination Techniques With Photodynamic Therapy Show Promise in Treatment of Pigmented Basal Cell Carcinomas
Skin Cancer Detection With AI: How Intelligent Is It?
2 Clarke Drive Cranbury, NJ 08512